Contraindications
- Previous hypersensitivity to gentamicin or other aminoglycoside antibiotics
- Myasthenia gravis
- Mitochondrial mutation m.1555A -> G
Cautions
- Liver disease - Patients with decompensated liver disease are at high risk of aminoglycoside induced renal failure and gentamicin may increase risk of hepatorenal syndrome. Cirrhotic patients may appear to have 'normal' creatinine levels masking renal dysfunction - use only when alternatives are unsuitable
- Any personal or family history of vestibular / auditory toxicity whilst on aminoglycosides - use only when no other suitable alternatives
- Creatinine Clearance <21ml/minute, ongoing AKI or oliguria
- If gentamicin is indicated, give the first dose and monitor closely before giving further doses - discuss with pharmacy if unsure whether to continue
- Co-administration with neurotoxic or nephrotoxic agents, e.g. neuromuscular blockers, nonsteroidal anti-inflammatory drugs, ACE Inhibitors, diuretics
- Patients with known conditions characterised by muscular weakness
Toxicity
- Monitor creatinine and any reduction in urine output daily - consider alternatives if creatinine rising (e.g. >15-20% increase) or patients become oliguric
- All patients should be told to monitor for:
- reduction in urine output
- Allergic reactions: including rash, itch, fever,
shortness of breath, a tight chest or wheezing,
chills or shivers, swelling or redness of the skin - Hearing or balance problems e.g. tinnitus, hearing loss, dizziness or difficulty in keeping your balance
- Visual disturbances
See full SAPG Gentamicin guidelines HERE for further details. Always seek advice from infection specialist if gentamicin is required beyond 3-4 days.
